Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis.

Raphael J Landovitz, Sinead Delany-Moretlwe, Jessica M Fogel, Mark A Marzinke, Estelle Piwowar-Manning, Paul Richardson, Elias K Halvas, John W Mellors, Deborah Persaud, Ryan Kofron, Marybeth McCauley, Scott Rose, Alex R Rinehart, James F Rooney, Adeola Adeyeye, Myron S Cohen, Deborah Donnell, Mina C Hosseinipour, Beatriz Grinsztejn, Susan H Eshleman, HPTN 083 and 084 Study Teams
Author Information
  1. Raphael J Landovitz: University of California, Los Angeles, Los Angeles, CA rlandovitz@mednet.ucla.edu.
  2. Sinead Delany-Moretlwe: University of the Witwatersrand, Johannesburg, South Africa.
  3. Jessica M Fogel: Johns Hopkins University, Baltimore, MD.
  4. Mark A Marzinke: Johns Hopkins University, Baltimore, MD.
  5. Estelle Piwowar-Manning: Johns Hopkins University, Baltimore, MD.
  6. Paul Richardson: Johns Hopkins University, Baltimore, MD.
  7. Elias K Halvas: University of Pittsburgh, Pittsburgh, PA.
  8. John W Mellors: University of Pittsburgh, Pittsburgh, PA.
  9. Deborah Persaud: Johns Hopkins University, Baltimore, MD.
  10. Ryan Kofron: University of California, Los Angeles, Los Angeles, CA.
  11. Marybeth McCauley: FHI 360, Durham, NC.
  12. Scott Rose: FHI 360, Durham, NC.
  13. Alex R Rinehart: ViiV Healthcare, Research Triangle Park, NC.
  14. James F Rooney: Gilead Sciences, Foster City, CA.
  15. Adeola Adeyeye: National Institutes of Health, Bethesda, MD.
  16. Myron S Cohen: University of North Carolina at Chapel Hill, Chapel Hill, NC.
  17. Deborah Donnell: Fred Hutchinson Cancer Center, Seattle, WA.
  18. Mina C Hosseinipour: University of North Carolina at Chapel Hill, Chapel Hill, NC.
  19. Beatriz Grinsztejn: Instituto de Pesquisa Clinica Evandro Chagas-Fiocruz, Rio de Janeiro, Brazil.
  20. Susan H Eshleman: Johns Hopkins University, Baltimore, MD.

Abstract

No abstract text available.

References

  1. N Engl J Med. 2021 Aug 12;385(7):595-608 [PMID: 34379922]
  2. Lancet. 2022 May 7;399(10337):1779-1789 [PMID: 35378077]
  3. J Infect Dis. 2022 Dec 13;226(12):2170-2180 [PMID: 36240386]
  4. Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0005323 [PMID: 36995219]

Grants

  1. U01 AI068619/NIAID NIH HHS
  2. UM1 AI069424/NIAID NIH HHS
  3. U01 AI069463/NIAID NIH HHS
  4. UM1 AI068619/NIAID NIH HHS
  5. UM1 AI068613/NIAID NIH HHS
  6. P30 AI050410/NIAID NIH HHS
  7. UM1 AI068617/NIAID NIH HHS